American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

Irritable bowel syndrome (IBS) and chronic idiopathic constipation ((CIC) also referred to as functional constipation) are two of the most common functional gastrointestinal disorders worldwide. IBS is a global problem, with anywhere from 5 to 15% of the general population experiencing symptoms that would satisfy a definition of IBS (1,2). In a systematic review on the global prevalence of IBS, Lovell and Ford (1) documented a pooled prevalence of 11% with all regions of the world suffering from this disorder at similar rates. Given its prevalence, the frequency of symptoms, and their associated debility for many patients and the fact that IBS typically occurs in younger adulthood, an important period for furthering education, embarking on careers, and/or raising families, the socioeconomic impact of IBS is considerable. These indirect medical costs are frequently compounded by the direct medical costs related to additional medical tests and the use of various medical and nonmedical remedies that may have limited impact. CIC is equally common; in another systematic review, Suares and Ford (3) reported a pooled prevalence of 14%, and also noted that constipation was more common in females, in older subjects, and those of lower socioeconomic status (3). Chronic constipation has also been linked to impaired quality of life (4), most notably among the elderly (5). Neither IBS nor CIC are associated with abnormal radiologic or endoscopic abnormalities, nor are they associated with a reliable biomarker; diagnosis currently rests entirely, therefore, on clinical grounds. Although a number of clinical definitions of both IBS and CIC have been proposed, the criteria developed through the Rome process, currently in its third iteration, have been those most widely employed in clinical trials and, therefore, most relevant to any review of the literature on the management of these disorders. According to Rome III, IBS is defined on the basis of the presence of: Recurrent abdominal pain or discomfort at least 3 days/month in the past 3 months associated with two or more of the following: Improvement with defecation Onset associated with a change in frequency of stool Onset associated with a change in form (appearance) of stool These criteria should be fulfilled for the past 3 months with symptom onset at least 6 months before diagnosis (6). Rome III defines functional constipation as: the presence of two or more of the following: Straining during at least 25% of defecations Lumpy or hard stools in at least 25% of defecations Sensation of incomplete evacuation for at least 25% of defecations Sensation of anorectal obstruction/blockage for at least 25% of defecations Manual maneuvers to facilitate at least 25% of defecations (e.g., digital evacuation, support of the pelvic floor) Fewer than three defecations per week Furthermore, loose stools are rarely present without the use of laxatives and there are insufficient criteria for IBS. Again, these criteria should be fulfilled for the past 3 months with symptom onset at least 6 months before diagnosis (6). In Rome III, IBS is subtyped according to predominant bowel habit as IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), mixed and definition of bowel habit in on the of stool form by to the that IBS according to predominant bowel with that and may be to the of at of these is that symptoms may be a and may IBS during a and a IBS during another period in their there is general of the Rome they are employed in the of IBS and CIC in clinical more as as to of that the Rome process, of the definitions in systematic IBS is defined abdominal discomfort associated with bowel is defined as: a disorder defined as defecation and is by stool or stool a of incomplete evacuation, to or for maneuvers to CIC is defined as the presence of these symptoms for at least 3 months is important to that the Rome III criteria that with chronic constipation criteria for IBS, with pain or discomfort a in the In a CIC and IBS with constipation may be and have these also a for patients to these is that in this of of on IBS and these be in the of this therefore, was to the most systematic by the of on IBS from and CIC from have a of systematic on the of in IBS and have been systematic of for IBS and CIC in the past 5 have been in the and therefore, all these systematic of IBS and CIC and the the from of this was to the of in IBS and CIC with or the of in IBS according to predominant stool reported with IBS with and mixed as as with for both IBS and review that any definition of IBS or IBS, this a the criteria the or Rome or III this symptoms by any of the Rome criteria as as a trials with or trials for at the of the before IBS, the and that the the and laxatives to be for at least be trials to or more of the of in IBS or CIC symptoms Improvement in abdominal pain for IBS IBS symptom or abdominal pain for IBS number of stools per week during for CIC for of to and to and the of trials on IBS with the bowel syndrome and functional as medical and and IBS, and functional bowel of these the with with the or as and or the or of and these the with with the or as and or the or of these the with with the or as and of and these the with with the and or and of these the with with the or as and or the or of these the with with the or as and or the or of and these the with with the or as and or the or of these the with with the or as and or the or of these the with with the or of these the with with the as a and on CIC with the constipation or gastrointestinal as and or functional idiopathic chronic or the the pelvic and also of these the with with the or as and or the or of and these the with with the as and or the of and of these the with with the or as and or the or of these the with with the or of these the with with the and and the or of these the with with the or of these the with with the or as and of and these the with with the and or and was limited to with to of of the of relevant was also and and of that for and to in the for on for of according to the in the the to the to of of and of an and by the and by a on to developed was by the two in to a as all to be IBS, any of global IBS symptoms as a was as the this was in abdominal pain was any of global CIC symptoms as a was as the impact of was as a of IBS or CIC symptoms with there the and to a more of the of IBS as global IBS symptom or IBS symptom a with was should be noted that may be in IBS or CIC of the on than global symptoms or abdominal this was and was of the of this of reported the of was and/or the for this by in or in or of tests for number to is the number of patients would to and the for to an in symptoms, and the number to is the number of patients would to and the for to an as the of the from the and the is and is for of and the of and for the quality of and of for medical has been widely in and is by all gastrointestinal quality of the is on the as as the of of and that for the the of is as to on the to would change the of also as or according to the quality of the to all of and and this the or should be to most and or are to change in the of a that to most patients in most and is to change in the of of the for IBS is in the for the on the quality of that in and the for the of in the of the for CIC is in the for the on quality of the in and the for the of in of the of the quality of of of on for for quality of of for IBS according to for of for IBS according to of of on for for quality of of of on CIC according to for of for of CIC according to Irritable bowel syndrome and in IBS of in Although is of the most common of symptoms in IBS to and with of the have typically in the of a on their IBS have their to this or from IBS patients that they have an to are in IBS the prevalence of in is and in of gastrointestinal patients that that their symptoms or IBS symptoms to of patients the in a on their with and a of to a have that a of IBS patients to an that may their of in may symptoms in IBS of that in IBS to of relevant symptom and an week three patients of these the impact of in IBS. In a patients with IBS to on a or to of on of an In the reported that their symptoms as with in the symptom for abdominal with stool and in those a of these the of or as by by In a IBS patients to an on the presence of to various or a for and symptoms a global impact and the IBS with in the in the noted a in reported in those with to their third the of and IBS patients to a or their for those to the reported of their symptoms with of the stool frequency was in the of this was the of the the of in the of symptoms, or in the of IBS, is two and have been in clinical is that (e.g., of and with the may also be relevant to the of or the that any of the of an or of a in IBS the limited on the of in the management of IBS. and their in the management of IBS to be in IBS symptom in IBS. of symptom in IBS. of of is frequently to bowel for IBS, for frequently and abdominal In systematic review two additional for a of trials IBS by and two to In the to of and to of three of the of the or of a for the a of patients reported symptom for at least with was more than during the third of 3 months of symptom in the was by with in the and in the with to quality of was most common in the most of in IBS. on by trials These trials as of in 5 of the of was of of patients reported with of in the Although its use in the management of IBS is the status of in in IBS, is from may symptoms and and in in IBS. These to in of of that the and that the be relevant to IBS from the that a of an of on to IBS IBS Although has been linked to and and in the have been in IBS, the of the to or symptoms in IBS, is both and and in the have also been linked to IBS the of to IBS and in to the in and have been for on an basis by IBS they have been to in clinical of in IBS as have employed and in various and in Although the that more than of all IBS in to a prevalence of in IBS These may to to the that may an of the this a for in IBS. a has in clinical trials in and in global IBS symptoms as as in is important to that tests for in these the of of in IBS and in is insufficient to or in IBS. of in as a global symptoms, and in IBS. or be at this of insufficient and of in is at IBS symptoms and in IBS. of that the in IBS this was from as the In to should be noted that in and of on these are in two trials IBS patients that two of in IBS as in and in the there was was that in patients of patients to with symptoms with of to trials global IBS symptoms on a in there was of in IBS symptom both trials of systematic review and on in IBS and a of trials of these was a of a in the in form and in the was and in both and these two in there trials at of with the patients reported on that as a than of IBS with the of was in the of was the use of a of as as on widely and in a for and there was for the two and for the and patients reported in global IBS symptom or abdominal pain was a of in symptoms with on this for of for those or and that reported the of on symptom with with In the trials that this lower with with with was for on in the trials that this reported by of patients to any with of to with the of 6 that in IBS trials and as they was as symptoms a of IBS symptoms with with in patients with a in of with the of 5 5 trials in IBS was a in of the with the of three of trials reported in was in the and of Although to a for the in IBS, the of any reported in in the of IBS to be at this there is insufficient to a on the use of or in IBS, a for with and to be the that and the to on to as as a of to a or at this for this by the and has in IBS and to be and, the or use of an has at least the in has been in IBS have been for on an basis in the of IBS on the that and to IBS symptoms and pain in the and in IBS. are more common with than of patients with IBS. was the and and 3 criteria or all IBS, the fact that most trials before Rome definitions of trials the of IBS patients the quality of trials was with more than trials reported an of and reported on of all of was in all of the the in the various and are in the review that as a has a in IBS symptoms with the of 5 the of is and to as there are a number of of the for to and with of and of these in as as and for those that in was a in and have a on IBS symptoms, the of patients trials in this review reported with or In of patients to with of to the of was among those as with of experiencing any with the of most common and there reported in in any of the Although many of the relevant clinical trials are and from in of as a are in IBS, their use may be limited by all have been to be and on in quality and Furthermore, the of of the more may be limited to in IBS be in various through or that may also have of and of pain and its use for the of IBS. is to in IBS of is with than with of trials the of IBS patients with on this was at of with the reported a of on IBS symptoms with this was there was a in of with with the of 3 there was In these an of was employed in from to the of was among those as with of experiencing any In may be is in IBS. in IBS is insufficient to for use in IBS. of two was in of with trials the of IBS patients with patients and the on in both in in and in of the Although is an there is to support the use of for of global symptoms in IBS. in IBS the management of IBS on the that and among IBS in and that in these in pain of and are in symptom in IBS. are common and may of systematic review and on in IBS and there of trials the of IBS patients with on this of patients and another patients three of the at of with the in IBS symptoms with the of of on abdominal pain was reported by with of patients abdominal pain as with of to a of abdominal pain of with in patients and was associated with a in IBS symptoms with with the of in patients and was associated with a in IBS symptoms with with the of trials reported on In of patients to as with of to the of was among those as with of experiencing any was and more common in patients than those on and are in global symptom and pain in IBS. and as as have limited their use and than (e.g., of on for in IBS of are in IBS of systematic review and on in IBS and a of in patients quality of these trials was with a of more than of the of the would have been reported that of the trials at of was a in of with the of with In of the of the for of 3 of of the of 5 and of for the or the three have been in or two and a of be trials or as a reported by any Although to and of have their a of the have been to be in IBS. of in the management of IBS their a in gastrointestinal and and a of have been for in functional gastrointestinal disorders 3 have been to an important in and from the and a was in IBS and, of constipation and to its by the and was by the in a a management for suffering with IBS that is management was to a and in as and have been clinical are the gastrointestinal and of these the and gastrointestinal is an as a for the use of in with IBS with constipation in of was from the in is the that has been in in IBS is in the an of and has been is referred to the systematic review number of have been developed and have in constipation (e.g., that is in and the as on the or of these for the of IBS. in is in with IBS. of systematic review and and two a of trials patients for was at of with the IBS. trials or with the of two and a that there was a in of with the of and to be in the three and this all with of and patients that more than of any was that was more common with than with was has been reported with and was by the in In the the of a that of to with IBS. a management a and to patients and are of the and of in of these was as there and has been in most are more than at symptoms of IBS. of in the of IBS symptoms is to an of and as mixed have been developed for the of IBS. These are and should be noted that has been widely from the in and that this was to be more than in a of trials patients for or trials patients with IBS and mixed IBS quality of trials was of all and mixed for the of IBS and was In of in or mixed IBS nor was in with mixed as with the various and to that have been developed and in IBS, and both are in regions and by of of the use of in the is limited to with IBS and be in the of a is for the management of IBS in and is to for the of IBS. of is a similar to in the are that in the of and by and on the of of in an of that a of to the of the that in of and the by and the as as of pain clinical trials in IBS patients patients trials at of and there was was a in of with with the of 6 with was a in of with on abdominal pain of with on by two of the three trials among those with reported in all three was more with as with with the of 6 reported in two trials was also more common with with the of is to for the of IBS. of the on the of the in and the in through the and clinical trials of in IBS patients have been reported in three of these was a mixed population of IBS and CIC patients reported in IBS patients trials at of was a in of as with with the of and the three quality of was as according to as the on IBS symptoms was and the for the was to a Furthermore, for IBS patients from on reported in all three pooled for the two trials reported in a In the by reported by of patients as with of this was was also with with with this was more frequently among those was diarrhea In the two that pooled and of IBS patients and reported at least in of patients with of those was reported by of those to with of those to and are in IBS. both of these in with than their in an IBS for those have or as is to and by of on should be in IBS, the of on in IBS is that symptoms and pain in patients with IBS. of is a that as an and is by the for the of has been in patients with in with that stool frequency pain two of in IBS. In there was on bowel or discomfort and pain In the patients with IBS with the in bowel was with with at there was in on abdominal pain or defined as more than bowel per week with an of two or more from and of abdominal pain or with with there was in the of patients with a pain defined as a by or more from with most of these or is that pain or symptom in IBS. Chronic idiopathic constipation in CIC and stool frequency in patients with chronic idiopathic of is defined as that are of in the and are to the be of or and as a is as or on its with is the is is the of the in as from the in the and to and have been with in CIC and the quality of the use of these is trials the criteria for in this review a was with three trials and the be of or a to for with the was of the trials three and the a of and in and in the from the three trials that was with with the of and Although these trials be for the definitions of all and in all patients in the the that was to present at in this to be with In of among the three trials that the by these all reported with of a of and as a and reported in the of patients with during of incomplete evacuation, or of with In the number of bowel was also trials reported on the of in CIC patients to of per or noted with was reported reported the number of patients in of with and two with with of patients experiencing abdominal pain with of in or there symptom for gastrointestinal as abdominal and with with and in are in the management of chronic and and may the use of in are and laxatives in CIC laxatives or that in the with frequency and laxatives in is in symptoms of of is in symptoms of of with reported in patients with the of 3 trials at of and there was with in with the of trials at of and there was with laxatives on the number of reported the of abdominal or and laxatives in and are in of laxatives to and by the or in the a bowel laxatives and trials of reported and a of In of all patients to laxatives to to as with of those with the of 3 and with reported of the of experiencing any with laxatives was more frequently in the two trials Although by of the laxatives and and the laxatives and have been to be in chronic by have been and be at this laxatives have been in CIC is more than in symptoms of of a in the gastrointestinal and and are of of the the and gastrointestinal has the to symptoms of and are a was from the in of and be trials of in CIC patients of these trials the of in patients or laxatives the of in patients and older from to from to trials to be at of In an of all of patients to to as with of those to with the of 6 was noted the of the trials that of patients with to to as with of those to with the of 5 was a of those patients with laxatives reported that the of similar in patients laxatives with the a would have those patients use laxatives before in the with those of the that of patients with to to as with of those to the was trials reported of these more common in patients with than with and diarrhea all more common in patients with associated with an in and reported in and of in the and are in with the by more the that have as a is in the at this in CIC is in chronic idiopathic is with the of of the literature clinical trials a systematic review and In three trials have been reported in two a of CIC three trials at of of patients to to as with of with the of 6 was of the trials pooled of patients any with of In the third similar in number in both for diarrhea in from the as of the was more common in patients with is in the of chronic idiopathic of a on in CIC that three trials of in CIC two additional clinical trials of these two with the for of these the both the and the this trials of in CIC patients in trials at of the patients to to with of with the of and trials reported of with and both more frequently with in of abdominal pain or and are in CIC and are have been both in with than a their in a CIC for those have or or as be at this in CIC of the of constipation is pelvic or in pelvic or in impaired to that of and of the and as as the the (e.g., and and to incomplete defecation and incomplete evacuation, and digital and of pelvic incomplete or of the of the or of the and the of are to a to of use a of and to and by a and is in of constipation symptoms in CIC patients with of pelvic of of clinical trials of patients with CIC with pelvic they a relevant or or they with or of three clinical trials that patients that to a or trials or at of of to to the of the or a of of to the or was a of constipation with the of and of the trials reported on Although may in by a and in in the management of patients with CIC have of pelvic to the of this for many patients and their in CIC is a for as for CIC is the most important of the the of in the in and in the the has been as a for 3 of the in CIC patients three trials at of of employed from as as to as as In the to an of bowel per week for of the of the was reported for and of those to and of with for was more common in the patients with in CIC is insufficient to in of three trials in CIC patients of the trials the of or and was an In two trials the of was to be and a of two trials that reported on in constipation in CIC Although both trials in of the pooled in a as there was the two two trials that reported on number of bowel per week in was a in the number of bowel per week in bowel per week in the